Table 2.
Characteristic | Clinical trials (n = 20) | Observational studies (n = 30) |
---|---|---|
Geographic location, n (%) | ||
Asiaa | 11 (55%) | 11 (37%)b |
Europe | 6 (30%) | 13 (44%) |
North America | 2 (1%) | 3 (10%) |
South America | 0 (0%) | 1 (3%) |
Africa | 0 (0%) | 1 (3%) |
Multiple countries | 1 (5%) | 0 (0%) |
Not reported | 0 (0%) | 1 (3%) |
Study setting, n (%) | ||
Inpatient | 1 (5%) | 6 (20%) |
Outpatient | 7 (35%) | 13 (44%) |
Inpatient and outpatient | 4 (20%) | 1 (3%) |
Not reported | 8 (40%) | 10 (33%) |
Enrolment period, n (%) | ||
After 2000 | 9 (45%) | 12 (40%) |
Before 2000 | 1 (5%) | 5 (17%) |
Not reported | 10 (50%) | 13 (43%) |
aIncluding Turkey as an Asian country (Turkey is situated in both Asia and Europe, with its larger territory lying on the Asian continent)
bIncluding Russia